If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Product Launch » Influences on Market Entry
Download FREE Excerpt
7 Info Graphics
30 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Most pharmaceutical and medical device companies compensate health care providers for services such as speaker programs or advisory boards; at the same time, organizations understand the need to establish clear standards of payments to remain compliant and in good competitive standing in the industry. However, establishing precise fair market value (FMV) compensation rates is a challenge that requires taking into account multiple factors including thought leader tiers, geographic region, therapeutic area, and activity type.
Best Practices, LLC undertook benchmarking research to examine FMV levels and key trends in FMV compensation rates for thought leaders across KOL tiers, therapeutic areas, countries, and activities. The report also provides FMV compensation rates for event preparation and for non-specialists.
Best Practices, LLC engaged 30 Medical Affairs and Marketing leaders from 26 companies in the pharmaceutical & healthcare industry.
Biotech; Pharmaceutical; Biopharmaceutical; Health Care; Medical Device; Science; Consumer Products; Manufacturing; Research; Clinical Research; Laboratories; Communications
Acorda Therapeutics; AstraZeneca; Astellas; Apricus Biosciences; Inc.; AZURE8; LLC; Baylis Medical; Boehringer Ingelheim; BIOCAD; Thermo Fisher; Cipher Pharmaceuticals Inc.; Grunethal; GlaxoSmithKline ; LEO Pharma; Lung Biotechnology; Medtronic; Ortho-Clinical Diagnostics; Novartis; Pfizer; Phillips; Quintiles; Roche; Sanofi; Synchrony Healthcare Communications; Teva Neuroscience; Theravance; Vifor Pharma
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.